Scholars Central

Editor-in-Chief

Gjumrakch Aliev

President and CEO, GALLY International Biomedical Research Institute, USA

About

As published by the journal they serve.

Dr. Gjumrakch Aliev, M.D, Ph.D., the internationally recognized founder of Gally International, has more than a decade of research in the area of gerontology. Dr. Alievs extensive research is respected throughout the world and held in the highest regard. Dr. Aliev is one of the few scientists internationally recognized for his expertise in vascular and mitochondria factors in the pathogenesis of gerontology research fields especially in the atherosclerosis, ischemia/reperfusion, stroke, AD and on the models representing these conditions. In 1982 Gjumrakch Aliev graduated summa cum laude from the Azerbaijan Medical Institute in Baku, Azerbaijan receiving a M.D. degree in the fields of general medicine and health sciences. In 1989, he received his PhD (Summa Cum Laude) in the field of Cardiovascular Biology and Pathology, from the Ivanovo Medical Institute, Department of Electron Microscopy and Cell Pathology of the Institute of Human Morphology, Moscow State University, and Russian Cardiology Research Center, Moscow, Russia. He received postdoctoral training under the prestigious British Hearth Foundation Grant Program in the University College London (advisor Professor Geoffrey Burnstock, FRS) in the specialty neurosciences cardiology and medicine. Professor Aliev have developed research and educational programs in neuroscience, neurodegeneration, mitochondrial, cardiovascular, cerebrovascular, pathology, anatomy, histology, cancer, electron microscopy and other areas. Additionally, he has extensive experience managing dynamic academic research and teaching environments.

Research interests

  • Cell Biology
  • Biochemistry
  • and Functional Morphology of Cell and Tissues: Endothelial cells
  • Smooth Muscle Cells
  • Neurons and as well as Glial and Macrophages Cells
  • particularly atherogenesis
  • vascular remodeling
  • hypertension
  • ischemia/reperfusion
  • tumor angiogenesis
  • metastases and Alzheimer’s diseases
  • At the present time
  • Cytochrome C Oxidase activity
  • redox activity (Fe)
  • atherosclerosis
  • tumor angiogenesis
  • stroke

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.